TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SIGMA TAU

OncologyDermatology
Biotech

SIGMA TAU is a biotechnology company focused on Oncology, Dermatology.

1994
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 88%
1 drugs Phase 1: 1
Dermatology 13%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...